Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma

34Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hepatocellular carcinoma (HCC) has been shown to induce several immune suppressor mechanisms in patients. Our laboratory has been investigating different cellular mechanisms of immune suppression in patients with HCC. These suppressor mechanisms range from CD4+ regulatory T cells, functionally impaired dendritic cells, neutrophils, and monocytes to myeloid-derived suppressor cells. In vitro as well as in vivo studies have demonstrated that abrogation of the suppressor cells enhances or unmasks tumor-specific anti-tumor immune responses. We performed a literature search for immune suppressor cells in HCC, and here we provide a comprehensive summary of the latest studies in this field. Copyright © 2012 S. Karger AG, Basel.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhao, F., Korangy, F., & Greten, T. F. (2012). Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma. Digestive Diseases, 30(5), 477–482. https://doi.org/10.1159/000341695

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free